北京大学学报(医学版) ›› 2017, Vol. 49 ›› Issue (4): 617-621. doi: 10.3969/j.issn.1671-167X.2017.04.012

• 论著 • 上一篇    下一篇

单中心14年B超引导下经皮肾肿物穿刺活检经验

张玉祥1*,蒙学兵2*,姚林1,张崔建1,宋刚1,蔡林1,张争1△,李学松1,龚侃1,李淑清1,山刚志1,何群1,杨新宇1,何志嵩1,周利群1   

  1. (1. 北京大学第一医院泌尿外科,北京大学泌尿外科研究所,国家泌尿、男性生殖系统肿瘤研究中心,泌尿生殖系疾病(男)分子诊治北京市重点实验室, 北京100034; 2. 首都医科大学燕京医学院附属密云医院泌尿外科, 北京 101500)
  • 出版日期:2017-08-18 发布日期:2017-08-18
  • 通讯作者: 张争 E-mail: doczhz@aliyun.com

Percutaneous biopsy of the renal masses under ultrasound: a single-center 14 years experience

ZHANG Yu-xiang1*, MENG Xue-bing2*, YAO Lin1, ZHANG Cui-jian1, SONG Gang1, CAI Lin1, ZHANG Zheng1△, LI Xue-song1, GONG Kan1, LI Shu-qing1, SHAN Gang-zhi1, HE Qun1, YANG Xin-yu1, HE Zhi-song1, ZHOU Li-qun1   

  1. (1. Department of Urology, Peking University First Hospital; Institute of Urology, Peking University; National Urological Cancer Center; Urogenital Diseases (Male) Molecular Diagnosis and Treatment Center, Beijing 100034, China; 2. Department of Urology, Miyun Hospital of Yanjing Medical College, Capital Medical University, Beijing 101500, China)
  • Online:2017-08-18 Published:2017-08-18
  • Contact: ZHANG Zheng E-mail: doczhz@aliyun.com

摘要:  目的:评价B超引导下经皮肾肿物穿刺活检(renal masses biopsy, RMB)的诊断效果、安全性及在中晚期肾癌患者中的临床应用价值。方法:回顾性分析2001年4月至2014年12月在北京大学第一医院行B超引导下肾肿物穿刺活检的75例患者的临床病理资料,总结肿瘤大小、病理分型和分级、穿刺部位、穿刺针数以及诊断效果等数据,分组统计分析。结果:北京大学第一医院14年来B超引导下RMB数量呈明显增加趋势。共75例患者纳入本研究,确诊64例(85.3%),包括60例恶性肿瘤,4例良性病变;非诊断性穿刺11例(14.7%)。60例恶性肿瘤中,肾细胞癌37例(61.7%),尿路上皮癌13例(21.7%), 其他肿瘤10例(16.7%)。37例肾细胞癌中明确诊断病理学亚型33例(89.2%),无法明确病理学亚型4例(10.8%)。75例患者中,集合管癌占肾癌10.8%,鳞癌占尿路上皮癌23.1%,比例均高于已报道流行病学数据(2%,9.9%)。75例患者中,13例行手术治疗并取得术后病理,穿刺活检结果与术后病理结果相比,肿物良恶性、病理学亚型及病理分级诊断的准确率分别为100%、81.8%和60.0%。75例患者中1例(1.3%)出现轻微血尿,未出现其他相关并发症。结论:B超引导下RMB可准确诊断肾癌病理学亚型,指导晚期肾癌患者靶向治疗;RMB可较准确判断恶性程度较高的集合管癌、尿路上皮鳞癌,可为制定合理的治疗方案提供参考。

关键词: 癌, 肾细胞, 活组织检查, 诊断, 肿瘤, 组织学类型

Abstract: Objective: To assess the diagnostic rate, safety and clinical application of percutaneous renal masses biopsy for advanced renal cell carcinoma patients. Methods: In this retrospective study, we collected the data of renal masses from the patients who underwent renal masses biopsy under ultrasound from April 2001 to December 2014 in  Peking University First Hospital. A total of 75 patients who were undiagnosed or diagnosed with advanced renal cell carcinoma by the imageological method were enrolled in this study. The patient and lesion characteristics such as tumor size, pathology of tumor, histologic subtype, pathological grade, biopsied location and biopsied cores were recorded and analyzed. Results: Among all the 75 patients, biopsy was diagnostic in 64 cases (85.3%) and nondiagnostic in 11 cases (14.7%). Of the 64 diagnostic biopsies, 60 were malignant, including 37 (61.7%) renal cell carcinoma (RCC), 13 (21.7%) urothelial carcinoma and 10 (16.7%) other malignant masses. Of all the RCC subjects, 24 suffered from clear cell RCC, 5 papillary RCC, 3 collecting duct carcinomas, 1 unclassified RCC and 4 unknown subtypes. The 11 non-diagnostic biopsied samplings included inflammatory, blood and extrarenal tissue and normal renal tissue. The proportion of collecting duct carcinoma in RCC was 10.8% and the proportion of squamous carcinoma in urothelial carcinoma was 23.1%, which  were both higher than the previous research findings. For the male and female groups, non-diagnostic yields were 6.5% and 30.4%, respectively (P=0.022). Of all the 75 patients, 13 renal cell carcinoma patients underwent the surgical treatment and got the results of postoperative pathology. Comparing preoperative biopsy pathological diagnosis with postoperative pathological diagnosis, we found the diagnostic correct rates for benign and malignant lesions, pathological subtype and pathological grade were 100%, 81.8% and 60%, respectively. Mild macroscopic hematuria occurred in 1 case after RMB and there were no serious complications in all the cases. Conclusion: Percutaneous renal masses biopsy under ultrasound with a high diagnostic rate which can define the histologic subtype of renal cell carcinoma. With  targeted therapy, more and more patients whose evaluation suggests local advanced disease or metastatic tumors adopt renal tumor biopsy to define the histologic subtype, which could avoid unnecessary surgical treatment.

Key words: Carcinoma, renal cell, Biopsy, Diagnosis, Neoplasms, histologic type

中图分类号: 

  •  
[1] 陈心心, 唐哲, 乔艳春, 荣文笙. 北京市密云区4岁儿童患龋状况及其与龋活跃性检测的相关性[J]. 北京大学学报(医学版), 2024, 56(5): 833-838.
[2] 钟华, 李原, 徐丽玲, 白明欣, 苏茵. 18F-FDG PET/CT在风湿免疫病中的应用[J]. 北京大学学报(医学版), 2024, 56(5): 853-859.
[3] 李志存, 吴天俣, 梁磊, 范宇, 孟一森, 张骞. 穿刺活检单针阳性前列腺癌术后病理升级的危险因素分析及列线图模型构建[J]. 北京大学学报(医学版), 2024, 56(5): 896-901.
[4] 刘家骏, 刘国康, 朱玉虎. 免疫相关性重症肺炎1例[J]. 北京大学学报(医学版), 2024, 56(5): 932-937.
[5] 黄教悌,胡菁,韩博. 治疗相关神经内分泌前列腺癌机制研究与靶向治疗新进展[J]. 北京大学学报(医学版), 2024, 56(4): 557-561.
[6] 张树栋,谢睿扬. 机器人手术时代的肾癌合并腔静脉瘤栓治疗策略[J]. 北京大学学报(医学版), 2024, 56(4): 562-564.
[7] 邢念增,王明帅,杨飞亚,尹路,韩苏军. 前列腺免活检创新理念的临床实践及其应用前景[J]. 北京大学学报(医学版), 2024, 56(4): 565-566.
[8] 田宇轩,阮明健,刘毅,李德润,吴静云,沈棋,范宇,金杰. 双参数MRI改良PI-RADS评分4分和5分病灶的最大径对临床有意义前列腺癌的预测效果[J]. 北京大学学报(医学版), 2024, 56(4): 567-574.
[9] 姚凯烽,阮明健,李德润,田宇轩,陈宇珂,范宇,刘毅. 靶向穿刺联合区域系统穿刺对PI-RADS 4~5分患者的前列腺癌诊断效能[J]. 北京大学学报(医学版), 2024, 56(4): 575-581.
[10] 欧俊永,倪坤明,马潞林,王国良,颜野,杨斌,李庚午,宋昊东,陆敏,叶剑飞,张树栋. 肌层浸润性膀胱癌合并中高危前列腺癌患者的预后因素[J]. 北京大学学报(医学版), 2024, 56(4): 582-588.
[11] 颜野,李小龙,夏海缀,朱学华,张羽婷,张帆,刘可,刘承,马潞林. 前列腺癌根治术后远期膀胱过度活动症的危险因素[J]. 北京大学学报(医学版), 2024, 56(4): 589-593.
[12] 于书慧,韩佳凝,钟丽君,陈聪语,肖云翔,黄燕波,杨洋,车新艳. 术前盆底肌电生理参数对前列腺癌根治性切除术后早期尿失禁的预测价值[J]. 北京大学学报(医学版), 2024, 56(4): 594-599.
[13] 刘帅,刘磊,刘茁,张帆,马潞林,田晓军,侯小飞,王国良,赵磊,张树栋. 伴静脉癌栓的肾上腺皮质癌的临床治疗及预后[J]. 北京大学学报(医学版), 2024, 56(4): 624-630.
[14] 王滨帅,邱敏,张前进,田茂锋,刘磊,王国良,陆敏,田晓军,张树栋. 6例肾尤文肉瘤伴静脉瘤栓的诊治[J]. 北京大学学报(医学版), 2024, 56(4): 636-639.
[15] 虞乐,邓绍晖,张帆,颜野,叶剑飞,张树栋. 具有低度恶性潜能的多房囊性肾肿瘤的临床病理特征及预后[J]. 北京大学学报(医学版), 2024, 56(4): 661-666.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!